All In Biotech

Drug Trial Radar · NCT06805565

A Study of ONO-1110 in Patients With Social Anxiety Disorder

A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Social Anxiety Disorder

Last checked: Nov 19, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 115 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

115

Actual

Start

Jan 31, 2025

Primary completion

May 25, 2026

Study completion May 25, 2026

Sponsor

Lead sponsor
Ono Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Feb 3, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Social Anxiety Disorder

Conditions

  • Social Anxiety Disorder (SAD)

Interventions

  • ONO-1110Drug

    ONO-1110 tablets once a day

  • PlaceboDrug

    Placebo tablets once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in L-SAS J(Liebowitz Social Anxiety Scale Japanese version) total score from baseline to Week 12 of the treatment periodTime frame: Up to 19 weeks

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • Aisakura Clinic

    Fukuoka, Japan

  • AK Clinic

    Fukuoka, Japan

  • Hiro Mental Clinic

    Fukuoka, Japan

  • Hirota Clinic

    Fukuoka, Japan

  • Kokorono Clinic Hirao

    Fukuoka, Japan

  • Kokura Mental Clinic

    Fukuoka, Japan

  • Mental Clinic Sakurazaka

    Fukuoka, Japan

  • Shinseikai Kaku Mental Clinic

    Fukuoka, Japan

  • Uematsu Mental Clinic

    Fukuoka, Japan

  • Ichikawa Clinic

    Gunma, Japan

  • Higashi-Sapporo Mental Clinic

    Hokkaido, Japan

  • Kawamura Mental Clinic

    Hokkaido, Japan

  • Minami1jo Mental Clinic

    Hokkaido, Japan

  • Sapporo Kobushi Clinic

    Hokkaido, Japan

  • Shimode Mental Clinic

    Hokkaido, Japan

  • Tatsuta Clinic

    Hyōgo, Japan

  • Yutaka Clinic

    Kanagawa, Japan

  • Ai Clinic

    Miyazaki, Japan

  • Inoue Clinic

    Osaka, Japan

  • Yamaguchi Mental Clinic

    Tokushima, Japan

  • Harai Clinic

    Tokyo, Japan

  • Iidabashi Mental Clinic

    Tokyo, Japan

  • Ikebukuro Olive Mental Clinic

    Tokyo, Japan

  • Maynds Tower Mental Clinic

    Tokyo, Japan

  • Meguroeki Higashiguchi Mental Clinic

    Tokyo, Japan

  • Monzen-nakacho Mental Clinic

    Tokyo, Japan

  • Sangenjaya Nakamura Mental Clinic

    Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.